文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Transgender People and HIV Prevention: What We Know and What We Need to Know, a Call to Action.

作者信息

Mayer Kenneth H, Grinsztejn Beatriz, El-Sadr Wafaa M

机构信息

*Fenway Health/Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; †Fundação Oswaldo Cruz- FIOCRUZ, Rio de Janeiro, Brazil; and ‡ICAP at Columbia University Mailman School of Public Health, New York City, NY.

出版信息

J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3(Suppl 3):S207-9. doi: 10.1097/QAI.0000000000001086.


DOI:10.1097/QAI.0000000000001086
PMID:27429184
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4969053/
Abstract

Transgender people have been disproportionally affected by HIV, particularly transgender women. Their increased vulnerability to HIV is due to multiple issues, including biological (eg, increased efficiency of HIV transmission through receptive anal sex), epidemiological (eg, increased likelihood of having HIV-infected partners), structural (eg, social stigma limiting employment options), and individual factors (eg, internalized stigma leading to depression and substance use and risk-taking behaviors). There have been limited culturally appropriate HIV prevention interventions for transgender people, with many key prevention studies (eg, the iPrEx PrEP study) enrolling transgender women in a study focusing on men who have sex with men. This has resulted in limited understanding of the optimal ways to decrease transgender people's risk for HIV acquisition. The current supplement of JAIDS is designed to review what is known about HIV prevention for transgender people and to highlight new insights and best practices. The study reviews recent epidemiologic data, the pharmacology of HIV prophylactic agents in individuals who may be using exogenous hormones, and several recent multi-component interventions designed to address the lived experience of transgender people. Additionally, the study reviews the work going on at the NIH to address transgender health in general and HIV prevention in specific, as well as two important papers related to clinical trial design issues and the ethical conduct of research in this frequently disenfranchised population. It is the hope of the HIV Prevention Trials Network (HPTN) that this supplement will promote new knowledge around transgender health and the requisite issues that need to be addressed in order to conduct optimal clinical trials. The ultimate hope is that the information distilled in this supplement will inform investigators, clinicians, and public health officials in order to design further research to develop optimal prevention interventions for transgender people and to implement these interventions in ways that are culturally congruent and health promoting.

摘要

相似文献

[1]
Transgender People and HIV Prevention: What We Know and What We Need to Know, a Call to Action.

J Acquir Immune Defic Syndr. 2016-8-15

[2]
HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.

Lancet HIV. 2015-11-6

[3]
Understanding HIV risk and vulnerability among cisgender men with transgender partners.

Lancet HIV. 2020-2-4

[4]
Overcoming biological, behavioral, and structural vulnerabilities: new directions in research to decrease HIV transmission in men who have sex with men.

J Acquir Immune Defic Syndr. 2013-7

[5]
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.

Lancet HIV. 2018-2-18

[6]
Integrated and Gender-Affirming Transgender Clinical Care and Research.

J Acquir Immune Defic Syndr. 2016-8-15

[7]
The ethical imperative to reduce HIV stigma through community-engaged, status-neutral interventions designed with and for transgender women of colour in the United States.

J Int AIDS Soc. 2022-7

[8]
HIV-related care for transgender people: A systematic review of studies from around the world.

Soc Sci Med. 2019-4-28

[9]
HIV prevalence, risky behaviors, and discrimination experiences among transgender women in Cambodia: descriptive findings from a national integrated biological and behavioral survey.

BMC Int Health Hum Rights. 2017-5-23

[10]
Pre-Exposure Prophylaxis in Trans Populations: Providing Gender-Affirming Prevention for Trans People at High Risk of Acquiring HIV.

LGBT Health. 2018-9-29

引用本文的文献

[1]
The Role of Stigma and Resilience in Healthcare Engagement Among Transgender Latinas in the U.S. South: Baseline Findings from the ChiCAS Study.

J Immigr Minor Health. 2024-10

[2]
Prevalence and Correlates of Heavy Alcohol use among People Living with HIV who use Unregulated Drugs in Vancouver, Canada.

AIDS Behav. 2024-7

[3]
Transgender women in Kenya experience greater stigma, depressive symptoms, alcohol and drug use and risky sexual practices than cis-gendered men who have sex with men.

BMC Public Health. 2023-8-5

[4]
Non-uptake of HIV testing among trans men and trans women: cross-sectional study of client records from 2017 to 2019 in a community-based transgender health center in Metro Manila, Philippines.

BMC Public Health. 2022-9-16

[5]
PrEP Use and Adherence among Transgender Persons in Chicago, IL (SHIPP Study, 2014-2018, USA).

AIDS Behav. 2023-3

[6]
Self-Testing as a Hope to Reduce HIV in Transgender Women-Literature Review.

Int J Environ Res Public Health. 2022-7-30

[7]
A randomized controlled trial of an mHealth intervention for increasing access to HIV testing and care among young cisgender men and transgender women: the mLab App study protocol.

BMC Public Health. 2021-10-29

[8]
Global scoping review of HIV prevention research with transgender people: Transcending from trans-subsumed to trans-centred research.

J Int AIDS Soc. 2021-9

[9]
Evaluating Locally Developed Interventions to Promote PrEP Among Racially/Ethnically Diverse Transgender Women in the United States: A Unique CDC Initiative.

AIDS Educ Prev. 2021-8

[10]
How Has HIV Pre-Exposure Prophylaxis (PrEP) Changed Sex? A Review of Research in a New Era of Bio-behavioral HIV Prevention.

J Sex Res. 2021-9

本文引用的文献

[1]
Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People.

J Acquir Immune Defic Syndr. 2016-8-15

[2]
Design Issues in Transgender Studies.

J Acquir Immune Defic Syndr. 2016-8-15

[3]
Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research.

J Acquir Immune Defic Syndr. 2016-8-15

[4]
Integrated and Gender-Affirming Transgender Clinical Care and Research.

J Acquir Immune Defic Syndr. 2016-8-15

[5]
Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women.

J Acquir Immune Defic Syndr. 2016-8-15

[6]
Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis.

J Acquir Immune Defic Syndr. 2016-8-15

[7]
Behavioral Interventions to Prevent HIV Transmission and Acquisition for Transgender Women: A Critical Review.

J Acquir Immune Defic Syndr. 2016-8-15

[8]
Global Epidemiology of HIV Infection and Related Syndemics Affecting Transgender People.

J Acquir Immune Defic Syndr. 2016-8-15

[9]
Global health burden and needs of transgender populations: a review.

Lancet. 2016-7-23

[10]
Prevalence of Transgender Depends on the "Case" Definition: A Systematic Review.

J Sex Med. 2016-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索